Drug Shortage Report for APO-ALMOTRIPTAN

Last updated on 2019-05-14 History
Report ID 27
Drug Identification Number 02405792
Brand name APO-ALMOTRIPTAN
Common or Proper name ALMOTRIPTAN
Company Name APOTEX INC
Market Status DORMANT
Active Ingredient(s) ALMOTRIPTAN
Strength(s) 6.25MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 6 BLS
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2014-10-01
Estimated end date Unknown
Actual end date 2019-05-13
Shortage status Resolved
Updated date 2019-05-14
Company comments product is discontinued
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2019-05-14 English Compare
v4 2019-05-13 French Compare
v3 2019-05-13 English Compare
v2 2017-03-10 French Compare
v1 2017-03-10 English Compare

Showing 1 to 5 of 5